Join your peers for a packed day of clinical CPD learning at MIMS Learning Live London gponline.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from gponline.com Daily Mail and Mail on Sunday newspapers.
The National Institute for Health and Care Excellence (NICE) has issued its Final Draft Guidance (FDG) recommending empagliflozin (Jardiance®) as an option for the treatment of eligible adults with chronic kidney disease (CKD). 1 NICE has applied a streamlined process to this assessment of empagliflozin – an .
Tune in to the latest from singer-songwriters like Amy Mamtura, Raman Lama, Maryom Lollen, Kalyani Nair, Janaki Easwar ft Varkey & Friends, plus alt-rock/metal act Fallen Letters
Bayer announced that Kerendia® (finerenone) (10mg and 20mg), an oral, first-in-class non-steroidal, selective mineralocorticoid receptor (MR) antagonist,2 has been accepted for use within NHS Scotland by The Scottish Medicines Consortium (SMC) for the treatment of chronic kidney disease (stage 3 and 4 with albuminuria)
A record number of young advertising professionals will represent Sri Lanka at the Cannes Young Lions Competitions - Adaderana Biz English bizenglish.adaderana.lk - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from bizenglish.adaderana.lk Daily Mail and Mail on Sunday newspapers.